330
H.V. Huynh, J. Wu / Journal of Organometallic Chemistry 694 (2009) 323–331
13C{1H} NMR (126 MHz, CDCl3): d 172.1 (NCN), 138.9, 136.4, 135.4,
129.8, 125.1, 121.5 (Ar-C), 115.1 (CN), 40.2 (NCH2), 21.9 (p-CH3),
19.9 (o-CH3). trans-anti-3a: 1H NMR (500 MHz, CDCl3): d 7.22
(d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 7.03 (s, 4H, Ar-H), 6.90
(d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 5.18 (s, 4H, NCH2), 2.39 (s, 6H,
p-CH3), 2.23 (s, 12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d
172.2 (NCN), 140.1, 136.9, 135.6, 129.8, 125.3, 121.0 (Ar-C), 114.4
(CN), 39.4 (NCH2), 21.8 (p-CH3), 20.3 (o-CH3). Anal. Calc. for
C28H30Br2N6Pd: C, 46.92; H, 4.22; N, 11.72. Found: C, 47.20; H,
4.27; N, 11.73%. ESI-MS: m/z = 637 [MꢀBr]+, 739 [M+Na]+.
(OCH3), 53.1 (NCH2), 21.9 (p-CH3), 19.9 (o-CH3). trans-anti-4a: 1H
NMR (500 MHz, CDCl3): d 7.07 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid),
6.98 (s, 4H, Ar-H), 6.80 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 5.07
(s, 4H, NCH2), 3.73 (s, 6H, OCH3), 2.37 (s, 6H, p-CH3), 2.24
(s, 12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d 171.9 (C@O),
169.1 (NCN), 139.2, 137.0, 136.1, 129.5, 124.1, 122.8 (Ar-C), 53.2
(OCH3), 52.5 (NCH2), 21.8 (p-CH3), 20.4 (o-CH3). Anal. Calc. for
C30H36Br2N4O4Pd: C, 46.03; H, 4.64; N, 7.16. Found: C, 45.75; H,
4.71; N, 6.99%. ESI-MS: m/z = 703 [MꢀBr]+, 805 [M+Na]+. FT-IR
ꢀ1
~
m
(KBr pellet):
(C@O) 1757 cm (s).
4.11. trans-Dibromo-bis[1-mesityl-3-(2-cyanoethyl)imidazolin-2-
4.14. trans-Dibromo-bis[1-mesityl-3-(3-methylpropionate) imida-
ylidene]palladium(II) (3b)
zolin-2-ylidene]palladium(II) (4b)
Yield for both rotamers: 146 mg (0.196 mmol, 65%). trans-anti-
3b: 1H NMR (500 MHz, CDCl3): d 7.09 (d, 3J(H,H) = 1.9 Hz, 2H,
CHimid), 7.01 (s, 4H, Ar-H), 6.81 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid),
4.47 (t, 3J(H,H) = 7.0 Hz, 4H, NCH2), 2.90 (t, 3J(H,H) = 7.0 Hz, 4H,
CH2CN), 2.37 (s, 6H, p-CH3), 2.21 (s, 12H, o-CH3). 13C{1H} NMR
(126 MHz, CDCl3): d 171.3 (NCN), 139.8, 137.1, 136.0, 129.7,
124.2, 122.4 (Ar-C) 118.0 (CN), 47.4 (NCH2), 21.8 (p-CH3), 20.4
(CH2CN), 19.8 (o-CH3). trans-syn-3b: 1H NMR (500 MHz, CDCl3): d
7.15 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 6.83 (s, 4H, Ar-H), 6.74
(d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 4.92 (t, 3J(H,H) = 7.0 Hz, 4H,
NCH2), 3.44 (t, 3J(H,H) = 7.0 Hz, 4H, CH2CN), 2.47 (s, 6H, p-CH3),
1.92 (s, 12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d 171.1
(NCN), 138.7, 136.4, 135.5, 129.8, 124.7, 122.0 (Ar-C), 118.3 (CN),
47.6 (NCH2), 22.0 (p-CH3), 20.6 (CH2CN), 20.0 (o-CH3). Anal. Calc.
for C32H40Br2N4O4Pd: C, 47.40; H, 4.97; N, 6.91. Found: C, 45.80;
H, 5.07; N, 6.85% (the unsuccessful attempts to obtain better
values were attributed to the general lower thermal stability of
N-ethylene substituents.). ESI-MS: m/z = 665 [MꢀBr]+, 767
Yield for both rotamers: 217 mg (0.268 mmol, 89%). trans-syn-
4b: 1H NMR (500 MHz, CDCl3): d 7.09 (d, 3J(H,H) = 1.9 Hz, 2H,
CHimid), 6.82 (s, 4H, Ar-H), 6.65 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid),
4.93 (t, 3J(H,H) = 7.0 Hz, 4H, NCH2), 3.72 (s, 6H, OCH3), 3.33
(t, 3J(H,H) = 7.0 Hz, 4H, CH2C@O), 2.45 (s, 6H, p-CH3), 1.92 (s,
12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d 172.8 (C@O),
170.7 (NCN) 138.3, 136.6, 136.0, 129.6, 123.7, 122.4 (Ar-C), 52.6
(OCH3), 47.4 (NCH2), 36.2 (CH2C@O), 21.9 (p-CH3), 20.0 (o-CH3).
trans-anti-4b: 1H NMR (500 MHz, CDCl3): d 7.09 (d, 3J(H,H) =
1.9 Hz, 2H, CHimid), 6.96 (s, 4H, Ar-H), 6.70 (d, 3J(H,H) = 1.9 Hz,
2H, CHimid), 4.50 (t, 3J(H,H) = 7.0 Hz, 4H, NCH2), 3.69 (s, 6H,
OCH3), 2.86 (t, 3J(H,H) = 7.0 Hz, 4H, CH2C@O), 2.34 (s, 6H, p-CH3),
2.22 (s, 12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d 173.1
(C@O), 170.7 (NCN), 139.2, 137.2, 136.4, 129.4, 123.2, 123.0
(Ar-C), 52.4 (OCH3), 47.0 (NCH2), 35.6 (CH2C@O), 21.7 (p-CH3),
20.4 (o-CH3). Anal. Calc. for C30H34Br2N6Pd: C, 48.38; H, 4.60; N,
11.28. Found: C, 49.14; H, 5.31; N, 11.42% (the unsuccessful
attempts to obtain better values were attributed to the general
lower thermal stability of N-ethylene substituents.). ESI-MS:
~
+
ꢀ1
~
m (CN) 2253 cm (m).
[M+Na] . FT-IR (KBr pellet):
m/z = 731 [MꢀBr]+, 828 [M+NH4]+. FT-IR (KBr pellet):
m (C@O)
4.12. trans-Dibromo-bis[1-mesityl-3-(3-cyanopropyl)imidazolin-2-
1725 cmꢀ1 (s).
ylidene]palladium(II) (3c)
4.15. trans-Dibromo-bis[1-mesityl-3-(4-methylbutyrate)imidazolin-
Yield for both rotamers: 217 mg (0.280 mmol, 94%). trans-anti-
2-ylidene]palladium(II) (4c)
3c: 1H NMR (500 MHz, CDCl3):
d 7.00 (s, 4H, Ar-H), 6.99
(d, 3J(H,H) = 2.5 Hz, 2H, CHimid), 6.79 (d, 3J(H,H) = 1.9 Hz, 2H,
CHimid), 4.36 (t, 3J(H,H) = 7.0 Hz, 4H, NCH2), 2.39 (s, 6H, p-CH3),
2.22 (s, 12H, o-CH3), 2.22 (m, 4H, CH2CH2CH2), 2.08 (t, 3J(H,H) =
7.0 Hz, 4H, CH2CN). 13C{1H} NMR (126 MHz, CDCl3): d 170.4
(NCN), 139.6, 137.4, 136.4, 129.5, 124.0, 122.5 (Ar-C), 119.8 (CN),
50.0 (NCH2), 26.6 (CH2CN), 21.9 (p-CH3), 20.4 (o-CH3), 15.2
(CH2CH2CH2). trans-syn-3c: 1H NMR (500 MHz, CDCl3): 7.02
(d, 3J(H,H) = 2.5 Hz, 2H, CHimid), 6.83 (s, 4H, Ar-C), 6.72
(d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 4.77 (t, 3J(H,H) = 7.0 Hz, 4H,
NCH2), 2.62 (m, 4H, CH2CH2CH2), 2.50 (t, 3J(H,H) = 7.0 Hz, 4H,
CH2CN), 2.47 (s, 6H, p-CH3), 1.90 (s, 12H, o-CH3). 13C{1H} NMR
(126 MHz, CDCl3): d 170.2 (NCN), 138.4, 137.4, 136.0, 129.8,
124.5, 121.9 (Ar-C), 119.8 (CN), 50.0 (NCH2), 26.9 (CH2CN), 21.8
(p-CH3), 19.9 (o-CH3), 15.0 (CH2CH2CH2). Anal. Calc. for
C32H38Br2N6Pd: C, 49.73; H, 4.96; N, 10.87. Found: C, 49.48; H,
4.97; N, 10.68%. ESI-MS: m/z = 693 [MꢀBr]+, 795 [M+Na]+. FT-IR
Yield for both rotamers: 217 mg (0.290 mmol, 97%). trans-anti-
4c: 1H NMR (500 MHz, CDCl3):
d 6.97 (s, 4H, Ar-H), 6.95
(d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 6.74 (d, 3J(H,H) = 1.9 Hz, 2H,
CHimid), 4.27 (t, 3J(H,H) = 6.9 Hz, 4H, NCH2), 3.71 (s, 6H, OCH3),
2.49 (t, 3J(H,H) = 6.9 Hz, 4H, CH2CO), 2.35 (s, 6H, p-CH3), 2.23 (s,
12H, o-CH3), 2.15 (m, 4H, CH2CH2CH2). 13C{1H} NMR (126 MHz,
CDCl3): d 174.2 (C@O), 170.4 (NCN), 139.2, 137.3, 136.5, 129.5,
123.7, 121.8 (Ar-C), 52.3 (OCH3), 50.7 (NCH2), 31.4 (CH2C@O),
26.3 (CH2CH2CH2), 21.9 (p-CH3), 20.4 (o-CH3). trans-syn-4c: 1H
NMR (500 MHz, CDCl3): d 6.98 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid),
6.83 (s, 4H, Ar-H), 6.68 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid), 4.69
(t, 3J(H,H) = 6.9 Hz, 4H, NCH2), 3.71 (s, 6H, OCH3), 2.50
(t, 3J(H,H) = 6.9 Hz, 4H, CH2CO), 2.46 (s, 6H, p-CH3), 2.16 (m, 4H,
CH2CH2CH2), 1.92 (s, 12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3):
d 174.1 (C@O), 170.3 (NCN), 138.2, 136.6, 136.1, 129.6, 123.9, 121.6
(Ar-C), 52.4 (OCH3), 50.9 (NCH2), 31.3 (CH2C@O), 26.5
(CH2CH2CH2), 21.7 (p-CH3), 20.0 (o-CH3). Anal. Calc. for
C34H44Br2N4O4Pd: C, 48.68; H, 5.29; N, 6.68. Found: C, 48.80; H,
5.07; N, 6.85%. ESI-MS: m/z = 759 [MꢀBr]+, 862 [M+Na]+. FT-IR
ꢀ1
~
m
(KBr pellet):
(CN) 2246 cm (m).
4.13. trans-Dibromo-bis[1-mesityl-3-(methylacetyl)imidazolin-2-
ylidene]palladium(II) (4a)
ꢀ1
~
m
(KBr pellet):
(C@O) 1734 cm (s).
Yield for both rotamers: 218 mg (0.278 mmol, 93%). trans-syn-
4a: 1H NMR (500 MHz, CDCl3): d 7.10 (d, 3J(H,H) = 1.9 Hz, 2H,
CHimid), 6.84 (s, 4H, Ar-H), 6.74 (d, 3J(H,H) = 1.9 Hz, 2H, CHimid),
5.45 (s, 4H, NCH2), 3.84 (s, 6H, OCH3), 2.45 (s, 6H, p-CH3), 1.93 (s,
12H, o-CH3). 13C{1H} NMR (126 MHz, CDCl3): d 171.8 (C@O),
169.2 (NCN), 138.4, 136.6, 135.8, 129.6, 124.1, 122.9 (Ar-C), 53.4
4.16. trans-Dibromo-(mesitylimidazole)(1-mesityl-3-cyano-
ethylimidazolin-2-ylidene)palladium(II) (5)
Yield: 0.162 mg (0.234 mmol, 78%). 1H NMR (500 MHz, CDCl3):
d 8.02 (s, 1H, CHimid), 7.66 (s, 1H, CHimid), 7.33 (s, 1H, CHimid), 6.99
(s, 2H, Ar-H), 6.92 (s, 2H, Ar-H), 6.90 (s, 1H, CHimid), 6.70 (s, 1H,